Skip to content
THE ACTO TIMES
News
About
ACTO
THE ACTO TIMES
Editorial Board
Editorial Office
Current
Archives
Contact Us
Home
The ACTO Times Vol. 3 Issue 2 (2026 Spring Edition)
The ACTO Times 2026 Spring Edition
Download
Greetings from the ACTO chairperson
Greetings from the Editor-in Chief
ACTO-ASPI Co-organization: Advancing cell-based and emerging CGT ecosystem in Indonesia: the strategic role of the Indonesian Stem Cell Association (ASPI)
Spotlight: Regional CGT updates
The university perspective in cell & gene therapy in Indonesia: landscape, challenges, progress, and a strategic vision for breakthrough
Current picture in cell and stem cell therapy research in Vietnam
Cell and gene therapy in Vietnam: between scientific momentum and regulatory maturation
Japan’s dual-track regulatory framework for iPSCs therapies: lessons, limitations, and global implications
ACTO 2026 Annual meeting
17th annual meeting of ACTO
Discover Indonesia Through ACTO Annual Meeting 2026 in Jakarta
Academic highlight: iPSCs 20th Year
The 20-year journey of induced pluripotent stem cells (iPSCs) in regenerative medicine
Oxidative stress-driven metabolic reprogramming failure in MERRF patient’s iPSC-derived neurons: from neurodevelopmental deficits to novel therapies
iPSC-derived cardiac cell sheets for heart regeneration: Progress toward clinical translation
Therapeutic potentials of induced pluripotent and mesenchymal stem cell-derived exosomes
CGT COMMUNITY
Taiwan Association for Cellular Therapy (TACT)
From Formosa to the world: leading the new era of regenerative medicine and cellular therapy in Taiwan (Formosa Association of Regenerative Medicine/FARM)
Special Topic
Overcoming Manufacturing Bottlenecks in Cell and Gene Therapy: The Emergence of the Intelligent Development and Manufacturing Organization (IDMO) Model in Asia
Subscribe
Subscribed
THE ACTO TIMES
Sign me up
Already have a WordPress.com account?
Log in now.
THE ACTO TIMES
Subscribe
Subscribed
Sign up
Log in
Copy shortlink
Report this content
View post in Reader
Manage subscriptions
Collapse this bar